Paris, France

Louis A Chedid


Average Co-Inventor Count = 4.8

ph-index = 11

Forward Citations = 342(Granted Patents)


Company Filing History:


Years Active: 1976-2001

Loading Chart...
30 patents (USPTO):Explore Patents

Title: Insights into the Innovative Work of Louis A Chedid

Introduction: Louis A Chedid, a prominent inventor based in Paris, France, has made significant contributions to the field of pharmaceutical sciences with an impressive portfolio of 30 patents. His work primarily focuses on hematopoietic functions and the development of innovative pharmaceutical compositions aimed at enhancing human health.

Latest Patents: Among his latest patents, Chedid has developed MDP derivatives and conjugates with hematopoietic function stimulating activity. These innovative pharmaceutical compositions, which include Muramyl dipeptide derivatives and conjugates, are designed to induce hematopoietic stem cell stimulation and promote their mobilization into the circulating blood system. Additionally, his methods address the reduction of myelotoxic effects through these compositions, showcasing a dual focus on therapeutic utility and safety. Furthermore, Chedid has contributed to the advancement of enhanced immunogenic vaccines, underlining his commitment to improving healthcare outcomes.

Career Highlights: Throughout his career, Louis A Chedid has been associated with notable organizations, including the Agence Nationale De Valorisation De La Recherche (ANVAR). His work in these institutions has allowed him to expand his research and refine his innovations in the field of therapeutic agents.

Collaborations: Chedid has collaborated with esteemed colleagues in the research community, including Edgar Lederer and Pierre Lefrancier. These partnerships exemplify the spirit of collaboration that is essential for driving innovation and advancing scientific knowledge.

Conclusion: Louis A Chedid's contributions to pharmaceutical sciences reflect his dedication to innovation and the pursuit of effective therapeutic solutions. With his extensive portfolio of patents and collaborative efforts, he continues to influence the field positively, striving to improve health outcomes through novel pharmaceutical discoveries. His work exemplifies the synergy between science and innovation, underscoring the importance of ongoing research in the advancement of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…